Idiopathic Pulmonary Fibrosis

Latest News in Idiopathic Pulmonary Fibrosis

May 30, 2024

Single-Cell Profiling Reveals Insights About Immunity in Idiopathic Pulmonary Fibrosis – Yale School of Medicine

May 29, 2024

Idiopathic pulmonary fibrosis drug fails in phase 3 trial – UW Medicine Newsroom

May 24, 2024

Body mass index is associated with clinical outcomes in idiopathic pulmonary fibrosis – Nature.com

May 22, 2024

The Potential of ENV-101 in Treating Idiopathic Pulmonary Fibrosis and Cancer | 2024 ATS – Managed Healthcare Executive

May 20, 2024

Once-Promising Drug for Idiopathic Pulmonary Fibrosis Fails in Phase III Trial – Medpage Today

122 Active Idiopathic Pulmonary Fibrosis Clinical Trials

As of November 12, 2024

Source: clinicaltrials.gov

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

FIND

A DOCTOR EXPERT™

WHAT IS

CONGRESS DOING?